Related Experiment Videos
Novel FLT3 point mutation in acute myeloid leukaemia
Pier Paolo Piccaluga1, Michele Bianchini, Giovanni Martinelli
1Institute of Haematology and Medical Oncology L and A Seràgnoli, University of Bologna, S Orsola-Malpighi Hospital, Italy. ppicca@med.unibo.it
The Lancet. Oncology
|October 14, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Synthesis of Novel Tryptamine Derivatives and Their Biological Activity as Antitumor Agents.
Molecules (Basel, Switzerland)·2021
Estrogen and Androgen Receptor Inhibitors: Unexpected Allies in the Fight Against COVID-19.
Cell transplantation·2021
Axitinib in Ponatinib-Resistant B-Cell Acute Lymphoblastic Leukemia Harboring a T315L Mutation.
International journal of molecular sciences·2021
Concentration-QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia.
Cancer chemotherapy and pharmacology·2021
The molecular pathogenesis of multiple myeloma.
Hematology reports·2021
Next-generation sequencing improves BCR-ABL1 mutation detection in Philadelphia chromosome-positive acute lymphoblastic leukaemia.
British journal of haematology·2021
Commentary on "Amelanotic Melanoma With Features of Keratinocytic Tumor on Reflectance Confocal Microscopy".
Journal of cutaneous pathology·2026
Paucibacillary Tuberculous Meningitis with Clinical-Radiological Dissociation: A Diagnostic Challenge.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Cluster of imported cutaneous leishmaniasis due to Leishmania major among travellers returning from central Tunisia, France, October 2025 to May 2026.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026